| Chinese Glioma Genome Atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients Z Zhao, KN Zhang, Q Wang, G Li, F Zeng, Y Zhang, F Wu, R Chai, Z Wang, ... Genomics, Proteomics and Bioinformatics 19 (1), 1-12, 2021 | 625 | 2021 |
| circRNA disease: a manually curated database of experimentally supported circRNA-disease associations Z Zhao, K Wang, F Wu, W Wang, K Zhang, H Hu, Y Liu, T Jiang Cell death & disease 9 (5), 475, 2018 | 194 | 2018 |
| m6A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas RC Chai, F Wu, QX Wang, S Zhang, KN Zhang, YQ Liu, Z Zhao, T Jiang, ... Aging (Albany NY) 11 (4), 1204, 2019 | 181 | 2019 |
| YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma RC Chai, YZ Chang, X Chang, B Pang, SY An, KN Zhang, YH Chang, ... Journal of hematology & oncology 14, 1-16, 2021 | 113 | 2021 |
| METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma YZ Chang, RC Chai, B Pang, X Chang, SY An, KN Zhang, T Jiang, ... Cancer letters 511, 36-46, 2021 | 110 | 2021 |
| Outcomes of endoscopic and microscopic transsphenoidal surgery on non‐functioning pituitary adenomas: a systematic review and meta‐analysis SY Yu, Q Du, SY Yao, KN Zhang, J Wang, Z Zhu, XB Jiang Journal of cellular and molecular medicine 22 (3), 2023-2027, 2018 | 56 | 2018 |
| Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma RC Chai, KN Zhang, YZ Chang, F Wu, YQ Liu, Z Zhao, KY Wang, ... Carcinogenesis 40 (10), 1229-1239, 2019 | 50 | 2019 |
| Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma R Chai, G Li, Y Liu, K Zhang, Z Zhao, F Wu, Y Chang, B Pang, J Li, Y Li, ... Cancer Biology & Medicine 18 (1), 271, 2021 | 49 | 2021 |
| Survivin is a prognostic indicator in glioblastoma and may be a target of microRNA‑218 X Tong, P Yang, K Wang, Y Liu, X Liu, X Shan, R Huang, K Zhang, ... Oncology letters 18 (1), 359-367, 2019 | 38 | 2019 |
| Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma F Wu, Z Zhao, R Chai, Y Liu, K Wang, Z Wang, G Li, R Huang, H Jiang, ... Cancer Cell International 18, 1-10, 2018 | 38 | 2018 |
| A novel analytical model of MGMT methylation pyrosequencing offers improved predictive performance in patients with gliomas RC Chai, YQ Liu, KN Zhang, F Wu, Z Zhao, KY Wang, T Jiang, YZ Wang Modern Pathology 32 (1), 4-15, 2019 | 37 | 2019 |
| Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA K Zhang, X Liu, G Li, X Chang, S Li, J Chen, Z Zhao, J Wang, T Jiang, ... Cancer biology & medicine 19 (10), 1460, 2022 | 31 | 2022 |
| A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma R Chai, K Zhang, K Wang, G Li, R Huang, Z Zhao, Y Liu, J Chen Journal of Cancer Research and Clinical Oncology 144, 439-447, 2018 | 31 | 2018 |
| Plasminogen activator urokinase receptor implies immunosuppressive features and acts as an unfavorable prognostic biomarker in glioma F Zeng, G Li, X Liu, K Zhang, H Huang, T Jiang, Y Zhang The oncologist 26 (8), e1460-e1469, 2021 | 30 | 2021 |
| Combinations of four or more CpGs methylation present equivalent predictive value for MGMT expression and temozolomide therapeutic prognosis in gliomas RC Chai, KN Zhang, YQ Liu, F Wu, Z Zhao, KY Wang, T Jiang, YZ Wang CNS neuroscience & therapeutics 25 (3), 314-322, 2019 | 30 | 2019 |
| RGS16 promotes glioma progression and serves as a prognostic factor R Huang, G Li, Z Zhao, F Zeng, K Zhang, Y Liu, K Wang, H Hu CNS Neuroscience & Therapeutics 26 (8), 791-803, 2020 | 28 | 2020 |
| Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma RC Chai, N Wang, YZ Chang, KN Zhang, JJ Li, JJ Niu, F Wu, YQ Liu, ... Cancer Cell International 19, 1-13, 2019 | 26 | 2019 |
| RNA processing genes characterize RNA splicing and further stratify lower-grade glioma RC Chai, YM Li, KN Zhang, YZ Chang, YQ Liu, Z Zhao, ZL Wang, ... JCI insight 4 (17), 2019 | 26 | 2019 |
| Molecular and clinical characterization of TMEM71 expression at the transcriptional level in glioma KY Wang, RY Huang, XZ Tong, KN Zhang, YW Liu, F Zeng, HM Hu, ... CNS Neuroscience & Therapeutics 25 (9), 965-975, 2019 | 24 | 2019 |
| ADAMTSL4, a secreted glycoprotein, is a novel immune‐related biomarker for primary glioblastoma multiforme Z Zhao, KN Zhang, RC Chai, KY Wang, RY Huang, GZ Li, YZ Wang, ... Disease markers 2019 (1), 1802620, 2019 | 24 | 2019 |
